Publikationen von U. Schmidt

Schmidt, U.; Gall-Kleebach, D.; Pfister, H.; Czesny, N.; Spoormaker, V. I.; Rein, T.; Uhr, M.; Bettecken, T.; Holsboer, F.; Ising, M.: The Munich PTSD Biomarker Study (MPBS). Pharmacopsychiatry 42 (5), S. 240 - 240 (2009)

Schmidt, U.; Touma, C.; Gassen, N.; Christian, L.; Asmus, S.; Cox, M. B.; Hausch, F.; Schmidt, M. V.; Holsboer, F.; Rein, T.: Deletion of FKBP5 alters stress-related parameters in mice. Pharmacopsychiatry 42 (5), S. 240 - 240 (2009)

Schmidt, U.; Holsboer, F.; Rein, T.: Role of the hsp70 cochaperone BAG1 in glucocorticoid receptor function and stress-related diseases. Proceedings of the National Academy of Sciences of the United States of America 105 (49), S. E101 - E101 (2008)

Rosenhagen, M. C.; Schmidt, U.; Ebinger, M.; Nickel, T.; Uhr, M.: Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine - A case study. Journal of Clinical Psychopharmacology 28 (1), S. 105 - 107 (2008)

Rosenhagen, M. C.; Schmidt, U.; Weber, F.; Steiger, A.: Combination therapy of lamotrigine and escitalopram may cause myoclonus. Journal of Clinical Psychopharmacology 26 (3), S. 346 - 347 (2006)

Rosenhagen, M. C.; Schmidt, U.; Winkelmann, J.; Ebinger, M.; Knetsch, I.; Weber, F.: Olanzapine-induced oculogyric crisis. Journal of Clinical Psychopharmacology 26 (4), S. 431 - 431 (2006)

Rosenhagen, M. C.; Schüssler, P.; Schmidt, U.; Yassouridis, A.; Steiger, A.: Sleep-EEG effects of high-dose corticosteroid treatment in multiple sclerosis. Pharmacopsychiatry 38 (5), S. 273 - 273 (2005)

Wochnik, G. M.; Rüegg, J.; Abel, G. A.; Schmidt, U.; Holsboer, F.; Rein, T.: FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells. Journal of Biological Chemistry 280 (6), S. 4609 - 4616 (2005)

Wochnik, G. M.; Young, J. C.; Schmidt, U.; Holsboer, F.; Hartl, F. U.; Rein, T.: Inhibition of GR-mediated transcription by p23 requires interaction with Hsp90. FEBS Letters 560 (1-3), S. 35 - 38 (2004)

Rein, T.; Wochnik, G. M.; Schmidt, U.; Rosenhagen, M.; Holsboer, F.: Role of chaperones in signal transduction of the glucocorticoid receptor. Pharmacopsychiatry 36 (5), S. 255 - 255 (2003)

Schmidt, U.; Rosenhagen, M.; Holsboer, F.; Rein, T.: The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis. Pharmacopsychiatry 36 (5), S. 261 - 262 (2003)

Wochnik, G. M.; Abel, A.; Schmidt, U.; Holsboer, F.; Rein, T.: FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain. Pharmacopsychiatry 36 (5), S. 273 - 273 (2003)

Rosenhagen, M. C.; Sõti, C.; Schmidt, U.; Wochnik, G. M.; Hartl, F. U.; Holsboer, F.; Young, J. C.; Rein, T.: The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. Molecular Endocrinology 17 (10), S. 1991 - 2001 (2003)

Rosenhagen, M. C.; Young, J. C.; Wochnik, G. M.; Herr, A. S.; Schmidt, U.; Hartl, F. U.; Holsboer, F.; Rein, T.: Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins. Biological Chemistry 382, S. 499 - 504 (2001)

Schmidt, U.; Vermetten, E.: Integrating NIMH Research Domain Criteria (RDoC) into PTSD Research. In: Current topics in behavioral neurosciences, S. 1 - 23. Springer, Berlin, Heidelberg (2017)

Weeger, J.; Schmidt, U.; Uhr, M.; Steiger, A.: Cortisol response to nocturnal psychosocial stress in dependence of CRHR1 genotype. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S. S525 - S526. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, 06. Oktober 2018 - 09. Oktober 2018. (2019)